U.S. Stock Movement | Blackstone Rises Nearly 3%, Renewing Interest in Acquiring Medical Diagnostics Company Hologic
On Thursday, Blackstone rose nearly 3%, closing at $188.90. According to informed sources, Blackstone and TPG have rekindled their interest in acquiring the medical diagnostics company Hologic, which could become one of the largest healthcare privatization deals of the year. Hologic CEO Steve MacMillan's compensation terms and the recent decline in stock prices may be incentives for the sale. Informed sources indicate that both parties are currently conducting due diligence and a deal is not expected to be reached within the next month
According to Zhitong Finance APP, on Thursday, Blackstone (BX.US) rose nearly 3%, closing at $188.90. In terms of news, informed sources revealed that Blackstone Group and TPG have rekindled their interest in acquiring the medical diagnostics company Hologic, which could become one of the largest healthcare privatization deals of the year. Hologic's CEO Steve MacMillan's compensation terms and the recent decline in stock prices may be incentives for the sale. Informed sources stated that both parties are currently conducting due diligence and a deal is not expected to be reached within the next month
